Concerns Regarding Masataka et al.'s “Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan”
Neuropsychopharmacology Reports · 2025
DOI: 10.1002/npr2.70057 ↗Kurz gefasst
Leserbrief in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Zui C Narita. Beteiligte Einrichtung: Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan. Hauptthemen laut MEDLINE: Cannabis, Marijuana Use, Illicit Drugs, Marijuana Abuse. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Masataka et al.'s cannabis gateway study misrepresents the 43.8% probability of cannabis users transitioning to illegal drugs as "rare," and misuses regression via the Table 2 Fallacy. These critical issues discredit their conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Japan.
ORCID-Profile: Zui C Narita
Zitieren
APA
Narita, Z. C. (2025). Concerns Regarding Masataka et al.'s “Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan”. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70057
Vancouver
Narita ZC. Concerns Regarding Masataka et al.'s “Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan”. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.70057
BibTeX
@article{Narita2025,
author = {Narita, Zui C},
title = {Concerns Regarding Masataka et al.'s “Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan”},
journal = {Neuropsychopharmacology Reports},
year = {2025},
doi = {10.1002/npr2.70057}
}
EUVIMED